Amarin PLC Research Development Over Time
| AMRN Stock | USD 14.86 0.25 1.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Amarin PLC Performance and Amarin PLC Correlation. Will Biotechnology sector continue expanding? Could Amarin diversify its offerings? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amarin PLC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.94) | Earnings Share (4.20) | Revenue Per Share | Quarterly Revenue Growth 0.174 | Return On Assets |
Understanding Amarin PLC requires distinguishing between market price and book value, where the latter reflects Amarin's accounting equity. The concept of intrinsic value - what Amarin PLC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Amarin PLC's price substantially above or below its fundamental value.
Understanding that Amarin PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amarin PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Amarin PLC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Research Development Analysis
Compare Amarin PLC and related stocks such as GeoVax Labs, BioLineRx, and Tharimmune Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GOVX | 76.7 K | 4.3 M | 3 M | 2.9 M | 1.8 M | 1.7 M | 2 M | 2 M | 1.9 M | 1.9 M | 2.4 M | 15.6 M | 9.1 M | 20.7 M | 23.7 M | 27.3 M | 28.6 M |
| BLRX | 29 M | 11.2 M | 17.2 M | 12.2 M | 10.9 M | 11.5 M | 11.2 M | 19.5 M | 19.8 M | 23.4 M | 18.2 M | 19.5 M | 17.6 M | 12.5 M | 9.1 M | 8.2 M | 13.2 M |
| THAR | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 368.7 K | 847.3 K | 1.8 M | 2.3 M | 3.6 M | 6.4 M | 7.4 M | 7.7 M |
| AIMD | 644.4 K | 281.1 K | 199.6 K | 133 K | 133 K | 0.0 | 0.0 | 0.0 | 32.6 K | 52.5 K | 389 | 1.9 M | 6.8 M | 7.3 M | 8.4 M | 9.7 M | 10.2 M |
| LPCN | 3.1 M | 3.1 M | 2.3 M | 5.6 M | 15.5 M | 12.6 M | 8.1 M | 11 M | 6.5 M | 7.5 M | 9.7 M | 7.7 M | 8.6 M | 10.2 M | 7.4 M | 8.5 M | 9.1 M |
Amarin PLC and related stocks such as GeoVax Labs, BioLineRx, and Tharimmune Research Development description
My Equities
My Current Equities and Potential Positions
| Amarin PLC | AMRN |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | One Central Plaza, |
| Exchange | NASDAQ Exchange |
USD 14.86
Check out Amarin PLC Performance and Amarin PLC Correlation. To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Amarin PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.